Helios is a marker, not a driver, of human Treg stability AJ Lam, P Uday, JK Gillies, MK Levings European Journal of Immunology 52 (1), 75-84, 2022 | 51 | 2022 |
Harnessing advances in T regulatory cell biology for cellular therapy in transplantation AJ Lam, RE Hoeppli, MK Levings Transplantation 101 (10), 2277-2287, 2017 | 44 | 2017 |
Optimized CRISPR-mediated gene knockin reveals FOXP3-independent maintenance of human Treg identity AJ Lam, DTS Lin, JK Gillies, P Uday, AM Pesenacker, MS Kobor, ... Cell Reports 36 (5), 2021 | 43 | 2021 |
Innate control of tissue-reparative human regulatory T cells AJ Lam, KN MacDonald, AM Pesenacker, SC Juvet, KA Morishita, ... The Journal of Immunology 202 (8), 2195-2209, 2019 | 43 | 2019 |
Characterization of regulatory T cells in obese omental adipose tissue in humans D Wu, JM Han, X Yu, AJ Lam, RE Hoeppli, AM Pesenacker, Q Huang, ... European Journal of Immunology 49 (2), 336-347, 2019 | 41 | 2019 |
Janus and PI3-kinases mediate glucocorticoid resistance in activated chronic leukemia cells S Oppermann, AJ Lam, S Tung, Y Shi, L McCaw, G Wang, J Ylanko, ... Oncotarget 7 (45), 72608, 2016 | 17 | 2016 |
PTEN is required for human Treg suppression of costimulation in vitro AJ Lam, M Haque, KA Ward‐Hartstonge, P Uday, CM Wardell, JK Gillies, ... European Journal of Immunology 52 (9), 1482-1497, 2022 | 8 | 2022 |
An optimized method to measure human FOXP3+ regulatory T cells from multiple tissue types using mass cytometry NAJ Dawson, AJ Lam, L Cook, RE Hoeppli, R Broady, AM Pesenacker, ... European Journal of Immunology 48 (8), 1415-1419, 2018 | 8 | 2018 |
Suppression of human dendritic cells by regulatory T cells Q Huang, AJ Lam, DA Boardman, NAJ Dawson, MK Levings Bio-protocol 11 (21), e4217-e4217, 2021 | 5 | 2021 |
PHLPP signaling in immune cells G Lordén, AJ Lam, MK Levings, AC Newton PI3K and AKT Isoforms in Immunity: Mechanisms and Therapeutic Opportunities …, 2022 | 4 | 2022 |
Modelling graft-versus-host disease in mice using human peripheral blood mononuclear cells M Haque, DA Boardman, AJ Lam, KN MacDonald, L Sanderink, Q Huang, ... Bio Protoc 12 (23), e4566, 2022 | 3 | 2022 |
Human regulatory T cell potential for tissue repair via IL-33/ST2 and amphiregulin AJ Lam, H Huang, JG Pan, SS Sidhu, G Charron, SM Ivison, JD Rioux, ... Transplantation 102, S331, 2018 | 1 | 2018 |
A germline heterozygous dominant negative IKZF2 variant causing syndromic primary immune regulatory disorder and ICHAD HY Lu, M Vaseghi-Shanjani, AJ Lam, M Sharma, A Mohajeri, J Gillies, ... medRxiv, 2023.09. 09.23295301, 2023 | | 2023 |
Developing next-generation regulatory T cell therapeutics AJ Lam University of British Columbia, 2021 | | 2021 |